In case of recurrent high risk non–muscle-invasive bladder cancer, radical cystectomy is recommended because of its oncologic superiority over further conservative treatments. Major surgery greatly affects quality of life, and patients may prefer to preserve the native bladder. Device-assisted therapy, which resulted in satisfactory oncologic results, especially in selected patients, shows promise and is worth further careful evaluation.
Di Gianfrancesco, L., Ragonese, M., Palermo, G., Sacco, E., Bassi, P., Racioppi, M., Second-Line Conservative Device-Assisted Intravesical Treatment in Selected Patients With Recurrent High-Risk Non–Muscle-Invasive Bladder Cancer, <<CLINICAL GENITOURINARY CANCER>>, 2021; (2021): N/A-N/A. [doi:10.1016/j.clgc.2020.11.002] [http://hdl.handle.net/10807/169426]
Second-Line Conservative Device-Assisted Intravesical Treatment in Selected Patients With Recurrent High-Risk Non–Muscle-Invasive Bladder Cancer
Ragonese, Mauro;Palermo, Giuseppe;Sacco, Emilio;Bassi, Pierfrancesco;Racioppi, Marco
2020
Abstract
In case of recurrent high risk non–muscle-invasive bladder cancer, radical cystectomy is recommended because of its oncologic superiority over further conservative treatments. Major surgery greatly affects quality of life, and patients may prefer to preserve the native bladder. Device-assisted therapy, which resulted in satisfactory oncologic results, especially in selected patients, shows promise and is worth further careful evaluation.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
